Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and also completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.

Dr. Khan led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia , as well as treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis.

She is the principle investigator evaluating novel therapies for parathyroid disease including PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpar, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia. In addition she was the principle investigator evaluating bisphosphonate therapy as well as the calcimetic cinacalcet for the medical management of primary hyperparathyroidism.

She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. In 2024 she was the recipient of the Woman Physician of the Year Award by the American College of Physicians (ACP) Ontario Chapter honoring an outstanding woman physician with a distinguished career in areas of exceptional patient care, medical education and/or research. She also received the ACP Humanitarian of the Year Award given for outstanding contributions to humanism in medicine and also recognizes scholarly activities in literature, philosophy, and ethics. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape

Aliya Khan is a Clinical Professor of Medicine in the Division of Endocrinology and Geriatrics at McMaster University, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University. She graduated from the University of Ottawa Medical School with honors. She trained in Internal Medicine, Geriatric Medicine and Endocrinology and also completed a fellowship in Metabolic Bone Disease at the University of Toronto. She has published over 200 scientific papers and numerous chapters and books on osteoporosis and parathyroid disease.

Dr. Khan led the development of global guidelines for parathyroid disease, osteonecrosis of the jaw, new diagnostic criteria for hypophosphatasia , as well as treatment guidelines for X-linked hypophosphatemia in addition to Canadian guidelines for osteoporosis.

She is the principle investigator evaluating novel therapies for parathyroid disease including PTH and PTH analogues as well PTH1receptor agonists for the treatment of hypoparathyroidism including palopegteriparatide, natpar, eneboparatide as well as the calcilytic molecule encalaret for the treatment of autosomal dominant hypocalcemia. In addition she was the principle investigator evaluating bisphosphonate therapy as well as the calcimetic cinacalcet for the medical management of primary hyperparathyroidism.

She has received numerous national and international awards including the Queen’s Diamond Jubilee Medal for excellence, International Hypoparathyroidism Award, International Osteoporosis Foundation award for publishing excellence and recognized by Osteoporosis Canada for outstanding contributions to research and education. In 2024 she was the recipient of the Woman Physician of the Year Award by the American College of Physicians (ACP) Ontario Chapter honoring an outstanding woman physician with a distinguished career in areas of exceptional patient care, medical education and/or research. She also received the ACP Humanitarian of the Year Award given for outstanding contributions to humanism in medicine and also recognizes scholarly activities in literature, philosophy, and ethics. She is recognized as being in the top 0.1% of the world experts in hyperparathyroidism by Expertscape

Christopher Patterson graduated from King’s College Hospital Medical School (University of London, England) in 1970, and after a rotating internship emigrated to Canada. He practiced as a general practitioner in Blind River, Northern Ontario, from 1971 until 1976.

He then entered residency in Internal Medicine at Queen’s University in Kingston, before subspecializing in Geriatric Medicine. He pursued postgraduate studies at the University of Western Ontario, Boston University and Guy’s Hospital London, before completing his geriatric residency and fellowship.

He joined the faculty of McMaster University in 1982 and received an RS McLaughlin Scholarship to study Clinical Epidemiology. He has led the Division of Geriatric Medicine (Department of Medicine) at McMaster, and Geriatric Services at Hamilton Health Sciences, the second largest teaching hospital in Canada. He was promoted to Professor in 1994. In 2005 he was awarded a Senior Visiting Fellowship at the Institute of Advanced Study, University of Bologna, Italy.

He has served as chief examiner in Geriatric Medicine for the Royal College of Physicians and Surgeons of Canada, and held positions on the executive of the Canadian Geriatrics Society and Geriatric Section of the Ontario Medical Association.

From 1985 until 2005 he served as a member of the Canadian Task Force on Preventive Health Care. He has also participated in various other federal and provincial government sponsored task forces.

He is a member of the editorial advisory board of the Canadian Pharmacists Association flagship publication, the CPS. In 1999 he co-chaired the Canadian Consensus Conference on Dementia with Dr Serge Gauthier, and was responsible for much of the editing of the subsequent publications in the Canadian Medical Association Journal and Canadian Journal of Neurological sciences. In 2005-6 he was a member of the steering committee of the third Canadian Consensus Conference on Diagnosis and Treatment of Dementia.

In 2006 he became Health Sciences Editor for the Canadian Journal on Aging, and was appointed to the Advisory Board of the Institute of Aging, one of the Canadian Institutes of Health Research.

Research Interests: Preventive health care for seniors including elder abuse and frailty as well as various aspects of cognitive disorders.

Christopher Patterson graduated from King’s College Hospital Medical School (University of London, England) in 1970, and after a rotating internship emigrated to Canada. He practiced as a general practitioner in Blind River, Northern Ontario, from 1971 until 1976.

He then entered residency in Internal Medicine at Queen’s University in Kingston, before subspecializing in Geriatric Medicine. He pursued postgraduate studies at the University of Western Ontario, Boston University and Guy’s Hospital London, before completing his geriatric residency and fellowship.

He joined the faculty of McMaster University in 1982 and received an RS McLaughlin Scholarship to study Clinical Epidemiology. He has led the Division of Geriatric Medicine (Department of Medicine) at McMaster, and Geriatric Services at Hamilton Health Sciences, the second largest teaching hospital in Canada. He was promoted to Professor in 1994. In 2005 he was awarded a Senior Visiting Fellowship at the Institute of Advanced Study, University of Bologna, Italy.

He has served as chief examiner in Geriatric Medicine for the Royal College of Physicians and Surgeons of Canada, and held positions on the executive of the Canadian Geriatrics Society and Geriatric Section of the Ontario Medical Association.

From 1985 until 2005 he served as a member of the Canadian Task Force on Preventive Health Care. He has also participated in various other federal and provincial government sponsored task forces.

He is a member of the editorial advisory board of the Canadian Pharmacists Association flagship publication, the CPS. In 1999 he co-chaired the Canadian Consensus Conference on Dementia with Dr Serge Gauthier, and was responsible for much of the editing of the subsequent publications in the Canadian Medical Association Journal and Canadian Journal of Neurological sciences. In 2005-6 he was a member of the steering committee of the third Canadian Consensus Conference on Diagnosis and Treatment of Dementia.

In 2006 he became Health Sciences Editor for the Canadian Journal on Aging, and was appointed to the Advisory Board of the Institute of Aging, one of the Canadian Institutes of Health Research.

Research Interests: Preventive health care for seniors including elder abuse and frailty as well as various aspects of cognitive disorders.

Dr. Alexandra Papaioannou is a professor in the Department of Medicine and a geriatrician at Hamilton Health Sciences.  She is Executive Director of the Geriatric Education and Research in Aging Sciences (GERAS) Centre at Hamilton Health Sciences.  She holds an Eli Lilly Research Chair at McMaster University.  She has a joint appointment in the Division of Rheumatology, and is past Director, Division of Geriatric Medicine, McMaster.  Dr Papaioannou is an Associate Member in the Department of Health Research Methods, Evidence and Impact, and a faculty member in the Medical Sciences, Physiology & Pharmacology Graduate Studies Program.  She is a member of the Gilbrea Centre Advisory Board, and McMaster Institute for Research on Aging (MIRA).  She is past chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and past Chair of the Board.  She is a member of the Scientific Advisors of Osteoporosis Canada, and the International Osteoporosis Foundation.  Dr. Papaioannou was lead author on the Osteoporosis Canada Guidelines published in Canadian Medical Association Journal (CMAJ) October 2010 and 2015.  Dr. Papaioannou was awarded an Ontario Career Scientist Award.  She is author of more than 300 peer reviewed publications with a focus on frailty, falls and fractures. She is the project lead for the Ontario Osteoporosis Strategy for Fracture Prevention in Long-term Care, and Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos).

Dr. Papaioannou has received a number of awards including the Ronald Cape Distinguished Service Award, to recognize an individual who has made an outstanding contribution to the health care of older adults in Canada, the Service Award for Geriatric Excellence (SAGE), Category: Executive/Senior Leadership, awarded by the Regional Geriatric Program central (RGPc), the  McMaster Department of Medicine Teaching Award for Postgraduate Teaching, the Ontario College of Family Physicians Certificate of Recognition for her contributions to primary care, the YWCA Hamilton Women of Distinction Award – Health & Wellness, and the Lindy Fraser Award from Osteoporosis Canada.

Dr. Alexandra Papaioannou is a professor in the Department of Medicine and a geriatrician at Hamilton Health Sciences.  She is Executive Director of the Geriatric Education and Research in Aging Sciences (GERAS) Centre at Hamilton Health Sciences.  She holds an Eli Lilly Research Chair at McMaster University.  She has a joint appointment in the Division of Rheumatology, and is past Director, Division of Geriatric Medicine, McMaster.  Dr Papaioannou is an Associate Member in the Department of Health Research Methods, Evidence and Impact, and a faculty member in the Medical Sciences, Physiology & Pharmacology Graduate Studies Program.  She is a member of the Gilbrea Centre Advisory Board, and McMaster Institute for Research on Aging (MIRA).  She is past chair of the Scientific Advisory Council of Osteoporosis Canada (OC) and past Chair of the Board.  She is a member of the Scientific Advisors of Osteoporosis Canada, and the International Osteoporosis Foundation.  Dr. Papaioannou was lead author on the Osteoporosis Canada Guidelines published in Canadian Medical Association Journal (CMAJ) October 2010 and 2015.  Dr. Papaioannou was awarded an Ontario Career Scientist Award.  She is author of more than 300 peer reviewed publications with a focus on frailty, falls and fractures. She is the project lead for the Ontario Osteoporosis Strategy for Fracture Prevention in Long-term Care, and Co-Director of the Hamilton Canadian Multi-Centre Osteoporosis Study (CaMos).

Dr. Papaioannou has received a number of awards including the Ronald Cape Distinguished Service Award, to recognize an individual who has made an outstanding contribution to the health care of older adults in Canada, the Service Award for Geriatric Excellence (SAGE), Category: Executive/Senior Leadership, awarded by the Regional Geriatric Program central (RGPc), the  McMaster Department of Medicine Teaching Award for Postgraduate Teaching, the Ontario College of Family Physicians Certificate of Recognition for her contributions to primary care, the YWCA Hamilton Women of Distinction Award – Health & Wellness, and the Lindy Fraser Award from Osteoporosis Canada.